WO2005011593A3 - Improved binding of pantoprazole to the acid pump - Google Patents
Improved binding of pantoprazole to the acid pump Download PDFInfo
- Publication number
- WO2005011593A3 WO2005011593A3 PCT/US2004/024678 US2004024678W WO2005011593A3 WO 2005011593 A3 WO2005011593 A3 WO 2005011593A3 US 2004024678 W US2004024678 W US 2004024678W WO 2005011593 A3 WO2005011593 A3 WO 2005011593A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pantoprazole
- improved binding
- acid pump
- acid
- pump
- Prior art date
Links
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 229960005019 pantoprazole Drugs 0.000 title abstract 2
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 abstract 1
- 108010083204 Proton Pumps Proteins 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49127303P | 2003-07-31 | 2003-07-31 | |
US60/491,273 | 2003-07-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005011593A2 WO2005011593A2 (en) | 2005-02-10 |
WO2005011593A3 true WO2005011593A3 (en) | 2005-09-01 |
Family
ID=34115485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/024678 WO2005011593A2 (en) | 2003-07-31 | 2004-07-30 | Improved binding of pantoprazole to the acid pump |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005011593A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102786483B (en) * | 2011-05-19 | 2016-03-30 | 复旦大学 | 4-(4-Phenylpiperazinyl) pharmaceutical usage of quinazoline derivative |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994025028A1 (en) * | 1993-04-27 | 1994-11-10 | Sepracor, Inc. | Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole |
-
2004
- 2004-07-30 WO PCT/US2004/024678 patent/WO2005011593A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994025028A1 (en) * | 1993-04-27 | 1994-11-10 | Sepracor, Inc. | Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole |
Non-Patent Citations (2)
Title |
---|
CURRENT OPINION IN GASTEROENTEROLOGY, vol. 19, no. 6, 2003, pages 519 - 525 * |
DATABASE BIOBASE [online] SCHUBERT M.K. ET AL: "Gastric Secretion", accession no. STN Database accession no. (2003267791) * |
Also Published As
Publication number | Publication date |
---|---|
WO2005011593A2 (en) | 2005-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005117870A3 (en) | Combination of proton pump inhibitor, buffering agent, and prokinetic agent | |
WO2003059251A3 (en) | Antibody targeting compounds | |
WO2007024705A3 (en) | Method of treating depression using a tnf-alpha antibody | |
WO2006037810A3 (en) | Protracted glp-1 compounds | |
WO2006015159A3 (en) | Potassium channel inhibitors | |
WO2006023651A3 (en) | Extended treatment of multiple sclerosis | |
WO2005047545A3 (en) | Microarray controls | |
WO2005030130A3 (en) | Isoquinoline potassium channel inhibitors | |
ZA200309934B (en) | Connector for timber brandering. | |
ZA200208489B (en) | Salt-sensitive, water-dispersible polymer composition. | |
WO2003093472A3 (en) | Cgrp binding nucleic acids | |
WO2004032908A3 (en) | Method of inhibiting angiogenesis | |
WO2005075412A3 (en) | Norbornane based cycloaliphatic compounds containing nitrile groups | |
WO2006039250A3 (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
WO2004075021A3 (en) | Molecular modeling methods | |
WO2006034035A3 (en) | Treatment of ischemia | |
WO2007039076A3 (en) | Niobium compound | |
WO2006036817A3 (en) | Fungal variants and uses thereof | |
WO2005034840A3 (en) | Identification of kinase inhibitors | |
WO2004013274A3 (en) | Ghrelin binding nucleic acids | |
WO2004092481A3 (en) | Method for the treatment of paper surfaces | |
WO2006029398A8 (en) | All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use | |
WO2005011593A3 (en) | Improved binding of pantoprazole to the acid pump | |
WO2008028032A3 (en) | Therapeutic substituted hydantoins and related compounds | |
ZA200407185B (en) | Binding element. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |